Related Experiment Videos
Comparative study between sonography, pathology and UGP in women with perimenopausal bleeding
O el-Ahmady1, M Gad, R el-Sheimy
1Tumor Marker Oncology Research Center, Al-Azhar University, Cairo, Egypt.
Anticancer Research
|July 1, 1996
Summary
Early detection of endometrial cancer is crucial. This study found that while Doppler endovaginal ultrasonography, DNA ploidy, and UGP show promise, no single method reliably distinguishes benign from malignant endometrial lesions.
Area of Science:
- Gynecology
- Oncology
- Medical Diagnostics
Background:
- Endometrial adenocarcinoma is the most common uterine malignancy.
- Adenomatous hyperplasia is a key precancerous endometrial lesion.
- Accurate early detection and differentiation of endometrial lesions are critical.
Purpose of the Study:
- To evaluate techniques for early detection of endometrial carcinoma.
- To differentiate endometrial hyperplasia with varying risks of progression.
- To assess the diagnostic value of Doppler EVS, DNA ploidy, and UGP.
Main Methods:
- Doppler endovaginal ultrasonography (EVS) for endometrial thickness and resistance index (RI).
- Histopathological examination of endometrial biopsy.
- DNA ploidy analysis.
- Urine UGP estimation via ELISA.
Main Results:
- No single parameter was sufficiently specific and sensitive for differentiating benign from malignant endometrial lesions.
- Doppler EVS detected 76% of endometrial abnormalities.
- DNA ploidy and UGP had equal sensitivity (60%) for endometrial carcinoma.
- DNA ploidy demonstrated higher specificity than UGP, with lower false positivity rates.
Conclusions:
- Current methods have limitations in definitively distinguishing endometrial hyperplasia from adenocarcinoma.
- Combined diagnostic approaches may improve early detection accuracy.
- Further research is needed to refine diagnostic strategies for endometrial precancerous and cancerous lesions.